Poseida Therapeutics (NASDAQ:PSTX) stock is soaring on Wednesday after the clinical-stage biotechnology company announced a deal with Roche (OTCMKTS:RHHBY). The agreement with Roche will have it ...

What’s Going On with PSTX Stock? News of the acquisition has sent PSTX stock surging this morning. Shares have skyrocketed 225% since markets opened, and they are showing no signs of slowing down.

Poseida Therapeutics (NASDAQ:PSTX) just reported results for the second quarter of 2024. Poseida Therapeutics reported earnings per share of -32 cents. This was above the analyst estimate for EPS of ...

When it comes to short-term investing or trading, they say "the trend is your friend." And there's no denying that this is the most profitable strategy. But making sure of the sustainability of a ...

Shares of Poseida Therapeutics, Inc. (PSTX) have been strong performers lately, with the stock up 196% over the past month. The stock hit a new 52-week high of $9.58 in the previous session. Poseida ...

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Poseida Therapeutics, Inc. (NASDAQ: PSTX) to Roche Holdings, Inc. for $9.00 per share in ...